SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-09-004203
Filing Date
2009-03-06
Accepted
2009-03-06 16:06:23
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y01248e10vk.htm 10-K 1113263
2 EX-23.1: CONSENT OF KESSELMAN & KESSELMAN y01248exv23w1.htm EX-23.1 1243
3 EX-31.1: CERTIFICATION y01248exv31w1.htm EX-31.1 8657
4 EX-31.2: CERTIFICATION y01248exv31w2.htm EX-31.2 8521
5 EX-32.1: CERTIFICATION y01248exv32w1.htm EX-32.1 3297
6 EX-32.2: CERTIFICATION y01248exv32w2.htm EX-32.2 3339
7 GRAPHIC y01248y0124801.gif GRAPHIC 12967
8 GRAPHIC y01248y0124802.gif GRAPHIC 11069
9 GRAPHIC y01248y0124803.gif GRAPHIC 11017
  Complete submission text file 0000950123-09-004203.txt   1188728
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33357 | Film No.: 09662887
SIC: 2836 Biological Products, (No Diagnostic Substances)